These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31586190)

  • 1. Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesicles.
    Dabbah M; Jarchowsky-Dolberg O; Attar-Schneider O; Tartakover Matalon S; Pasmanik-Chor M; Drucker L; Lishner M
    Carcinogenesis; 2020 Mar; 41(1):100-110. PubMed ID: 31586190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
    Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
    Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
    Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
    Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
    Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
    Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
    Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
    Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
    Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
    Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BM-MSCs-derived microvesicles promote allogeneic kidney graft survival through enhancing micro-146a expression of dendritic cells.
    Wu XQ; Yan TZ; Wang ZW; Wu X; Cao GH; Zhang C
    Immunol Lett; 2017 Nov; 191():55-62. PubMed ID: 28963073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of microvesicles from mesenchymal stem cells.
    Mohammadi MR; Riazifar M; Pone EJ; Yeri A; Van Keuren-Jensen K; Lässer C; Lotvall J; Zhao W
    Methods; 2020 May; 177():50-57. PubMed ID: 31669353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
    Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
    Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.
    Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X
    Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro.
    Guo HM; Sun L; Yang L; Liu XJ; Nie ZY; Luo JM
    Oncol Rep; 2018 Jun; 39(6):2873-2880. PubMed ID: 29693175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human bone marrow mesenchymal stem cell-derived microvesicles on the apoptosis of the multiple myeloma cell line U266.
    Vafaeizadeh M; Abroun S; Soufi Zomorrod M
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):299. PubMed ID: 38850382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.
    Sun L; Wang HX; Zhu XJ; Wu PH; Chen WQ; Zou P; Li QB; Chen ZC
    Acta Pharmacol Sin; 2014 Mar; 35(3):381-93. PubMed ID: 24374813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment.
    Nair-Gupta P; Rudnick SI; Luistro L; Smith M; McDaid R; Li Y; Pillarisetti K; Joseph J; Heidrich B; Packman K; Attar R; Gaudet F
    Blood Cancer J; 2020 Jun; 10(6):65. PubMed ID: 32483120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α.
    Lin S; Zhu B; Huang G; Zeng Q; Wang C
    Hum Cell; 2019 Jan; 32(1):64-74. PubMed ID: 30506278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.
    Martínez-Moreno M; Leiva M; Aguilera-Montilla N; Sevilla-Movilla S; Isern de Val S; Arellano-Sánchez N; Gutiérrez NC; Maldonado R; Martínez-López J; Buño I; García-Marco JA; Sánchez-Mateos P; Hidalgo A; García-Pardo A; Teixidó J
    Leukemia; 2016 Apr; 30(4):861-72. PubMed ID: 26658839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.
    Mognetti B; La Montagna G; Perrelli MG; Pagliaro P; Penna C
    J Cell Mol Med; 2013 Feb; 17(2):287-92. PubMed ID: 23301946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.